Reactions Weekly

, Volume 1658, Issue 1, pp 1–1 | Cite as

Alvogen's clindamycin product recalled in US

News item
  • 41 Downloads

Reference

  1. US Food and Drug Administration. Clindamycin Injection ADD-Vantage Vials by Alvogen: Recall - Lack of Sterility Assurance. Internet Document : 16 Jun 2017. Available from: URL: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm563546.htm

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations